Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Addiktiv Klinik ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   13.7% 11.4% 5.8% 8.1% 6.2% 3.2% 12.8% 12.8%   Credit score (0-100)   17 22 40 29 37 55 18 18   Credit rating   BB BB BBB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,464 4,600 5,798 4,996 6,439 7,753 0.0 0.0   EBITDA   78.5 123 339 146 555 549 0.0 0.0   EBIT   77.4 80.7 242 42.6 441 417 0.0 0.0   Pre-tax profit (PTP)   77.2 55.7 200.9 9.1 394.8 369.3 0.0 0.0   Net earnings   59.8 23.6 155.6 6.6 307.5 288.1 0.0 0.0   Pre-tax profit without non-rec. items   77.2 55.7 201 9.1 395 369 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   51.5 503 534 430 547 415 0.0 0.0   Shareholders equity total   110 133 289 295 603 891 541 541   Interest-bearing liabilities   0.0 0.0 59.6 9.2 8.6 0.0 0.0 0.0   Balance sheet total (assets)   1,267 1,918 2,213 1,911 2,760 3,014 541 541   Net Debt   -96.2 -112 -330 9.2 8.6 -882 -541 -541     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,464 4,600 5,798 4,996 6,439 7,753 0.0 0.0   Gross profit growth   0.0% 214.3% 26.0% -13.8% 28.9% 20.4% -100.0% 0.0%   Employees   8 6 6 5 6 8 0 0   Employee growth %   0.0% -25.0% 0.0% -16.7% 20.0% 33.3% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,267 1,918 2,213 1,911 2,760 3,014 541 541   Balance sheet change%   0.0% 51.4% 15.3% -13.6% 44.5% 9.2% -82.0% 0.0%   Added value   78.5 122.8 339.0 146.5 544.8 549.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   50 410 -67 -208 2 -264 -415 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.3% 1.8% 4.2% 0.9% 6.8% 5.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   6.1% 5.1% 11.7% 2.1% 19.0% 14.7% 0.0% 0.0%   ROI %   69.0% 62.5% 92.4% 12.4% 89.8% 53.4% 0.0% 0.0%   ROE %   54.5% 19.4% 73.7% 2.2% 68.4% 38.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   8.7% 6.6% 13.1% 15.5% 21.8% 29.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -122.6% -91.5% -97.3% 6.2% 1.6% -160.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 20.6% 3.1% 1.4% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 137.8% 101.2% 540.5% 1,269.6% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.5 0.6 0.6 0.8 1.0 0.0 0.0   Current Ratio   0.8 0.5 0.6 0.6 0.8 1.0 0.0 0.0   Cash and cash equivalent   96.2 112.3 389.3 0.0 0.0 882.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -181.2 -841.3 -648.8 -620.2 -410.8 -10.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   10 20 56 29 91 69 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   10 20 56 29 92 69 0 0   EBIT / employee   10 13 40 9 73 52 0 0   Net earnings / employee   7 4 26 1 51 36 0 0